Arrowhead Research | ARWR - Trade Creditors


Arrowhead Research reported $27.78M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Anika Therapeutics USD 6.24M 103K Jun/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Incyte USD 1.39B 1.16B Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
Ligand Pharmaceuticals USD 37.11M 33.87M Mar/2026
Merck USD 3.86B 541M Mar/2026
Moderna USD 167M 6M Jun/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Novartis USD 4.26B 64M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026
Xencor USD 12.65M 4.73M Jun/2026